Safety profile of asfotase alfa treatment of patients with hypophosphatasia: a pooled analysis
To read more please click on the link below.
Read Article
Related Articles
Dual X-ray absorptiometry has limited utility in detecting bone pathology in children with hypophosphatasia: A pooled post hoc analysis of asfotase alfa clinical trial data
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Five-Year Efficacy and Safety of Asfotase Alfa Therapy for Adults and Adolescents with Hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Responses